NCT04004754View on ClinicalTrials.gov

Outcomes of Complicated CL in Ethiopia Treated With Miltefosine

CompletedOBSERVATIONAL
Enrollment

94

Participants

Timeline

Start Date

May 7, 2019

Primary Completion Date

April 1, 2020

Study Completion Date

June 11, 2020

Conditions
Cutaneous Leishmaniases
Interventions
DRUG

Miltefosine (administration is not part of study procedures)

Patients who receive miltefosine in the routine setting will be asked to participate in the study to document their outcomes

Trial Locations (2)

Unknown

Boru Meda Hospital, Boru

Gondar University Hospital, Gonder

All Listed Sponsors
collaborator

University of Gondar

OTHER

collaborator

Boru Meda Hospital

UNKNOWN

lead

Institute of Tropical Medicine, Belgium

OTHER

NCT04004754 - Outcomes of Complicated CL in Ethiopia Treated With Miltefosine | Biotech Hunter | Biotech Hunter